Pune FDA Seizes Unlicensed Ayurvedic Medicines Worth ₹50.36 Lakh
Pune FDA Seizes Unlicensed Ayurvedic Medicines Worth ₹50.36 Lakh
Pune, July 14, 2026: The Food and Drug Administration (FDA), Maharashtra, has intensified its crackdown on violations in the pharmaceutical sector, seizing suspected unlicensed Ayurvedic medicines worth ₹50.36 lakh during a raid on an Ayurvedic store in Pune’s Shukrawar Peth.
The action was carried out after the FDA received information that Bhasma and Ras Ayurvedic medicines were being stored and sold without the required licence. Drug inspectors raided Kalpataru Ayurved, where they found a large quantity of the medicines stored in plastic bags, jars and bottles.
During the inspection, officials found that the products did not carry mandatory details such as batch numbers, manufacturing and expiry dates, manufacturer’s name and address, or licence number. The shop owner also failed to produce purchase invoices or documents establishing ownership of the stock.
As a result, the entire stock, valued at ₹50.36 lakh, was seized on suspicion of violating drug regulations. The FDA said the medicines will be examined further, and legal action will be initiated against those responsible based on the findings.
Solapur Medical Store Ordered to Suspend Operations
In a separate action, the FDA directed a medical store attached to Noble Hospital in Solapur to suspend its operations after an inspection revealed multiple violations.
The inspection was conducted following complaints that patients were being compelled to purchase medicines only from the hospital-linked pharmacy, Fatima Medical.
FDA officials found that patients were not being provided with prescriptions, while Schedule H and Schedule H1 medicines were allegedly being sold without valid doctor’s prescriptions. The inspection also revealed several other irregularities, including the absence of sales records, improper storage of temperature-sensitive medicines, failure to segregate expired medicines, and discrepancies in purchase and sales registers.
Following these findings, the FDA issued a “Stop Activity” order, directing the pharmacy to cease operations until compliance with the applicable regulations is ensured.
The enforcement drive is part of the FDA’s ongoing efforts to strengthen compliance with drug safety norms across Maharashtra after recent crackdowns on food adulteration and regulatory violations in the food and healthcare sectors.
